Vanguard Personalized Indexing Management, LLC Cytokinetics Inc Transaction History
Vanguard Personalized Indexing Management, LLC
- $6.46 Billion
- Q4 2024
A detailed history of Vanguard Personalized Indexing Management, LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Vanguard Personalized Indexing Management, LLC holds 6,986 shares of CYTK stock, worth $275,807. This represents 0.01% of its overall portfolio holdings.
Number of Shares
6,986
Previous 6,681
4.57%
Holding current value
$275,807
Previous $352,000
6.82%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding CYTK
# of Institutions
401Shares Held
115MCall Options Held
3.46MPut Options Held
1.86M-
Black Rock Inc. New York, NY14.7MShares$579 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.9MShares$470 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD10.8MShares$424 Million0.31% of portfolio
-
State Street Corp Boston, MA6.17MShares$243 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA2.84MShares$112 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $3.72B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...